Form D · Other Health Care

Rijuven Corp.

Wexford, PA · CIK 0001555522

Offering snapshot reported Jun 26, 2017 · SEC filing

Reported sold
$2.28M
Offering amount: $2.28M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 5, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 26, 2017Initial$2,283,040No comparison6SEC filing
Jan 8, 2015Initial$250,000No comparison1SEC filing
Nov 13, 2014Initial$500,000No comparison1SEC filing
Apr 3, 2014Initial$312,500No comparison2SEC filing
Jul 17, 2013Initial$543,879No comparison8SEC filing
Aug 23, 2012Initial$875,000No comparison8SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-289437
A portion of amount sold represents value of services rendered.

Source: Form D, filed Jun 26, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Evens Augustin Director, Executive
Justin Bass Executive
Raj Kapoor Director
Neil Niren Director
Taras Silecky Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
Wexford Town Center, Suite 104 10475 Perry Highway
Wexford, PA, 15090